Ac-225-MTI-201
225Ac-MTI-201, formerly 225Ac-DOTA-MC1RL, is a melanocortin 1 receptor ligand labeled [...]
Ac-225-FPI-2068
225Ac-FPI-2068 is a targeted alpha therapy (TAT) designed to deliver [...]
Ac-225-DOTA-YS5
225Ac-DOTA-YS5 is a CD46-targeted PET radiopharmaceutical under evaluation for therapeutic [...]
Pb-212-VMT-α-NET
212Pb-VMT-α-NET is the therapeutic analogue of the imaging agent 203Pb-VMT-α-NET [...]
Pb-212-GRPR
212Pb-GRPR (or 212Pb-DOTAM-GRPR1) is a radioimmunoconjugate comprised of ²¹²Pb, the [...]
Pb-212-ADVC001
212Pb-ADVC001 is an alpha-emitting PSMA targeting radiolabeled molecule developed in [...]
At-211-Parthanatine
211At-Parthanatine is an alpha-emitting radiopharmaceutical therapeutic that targets poly(adenosine-diphosphate-ribose) polymerase [...]
Lu-177-XT033
177Lu-XT033 is a PSMA targeting radiotherapeutic developed for the treatment [...]
Lu-177-LNC1010
177Lu-LNC1010 is a new radiolabeled drug targeting somatostatin receptors (sstr), [...]
Lu-177-LNC1004
177Lu-LNC1004 is a new radiolabeled drug targeting fibroblast activation protein [...]
